Ισραήλ - Εβραϊκά - Ministry of Health

easy-care ltd (of tec-o-pharm group) - רופא - for prevention or reduction of post surgical adhesion formation in the abdomino-pelvic area, for use in open surgery procedures. for use in laparoscopic and hysteroscopic surgical procedure

Ισραήλ - Εβραϊκά - Ministry of Health

neopharm scientific ltd. - כלל האוכלוסיה - for general weight management and the prevention and treatment of obesity

Ισραήλ - Εβραϊκά - Ministry of Health

טבע מדיקל (שיווק) בע"מ - אחות - disposable devices used in the prevention of accidental needle stick injuries

Ισραήλ - Εβραϊκά - Ministry of Health

זהב ישראל - שיפור מראה העור

Ισραήλ - Εβραϊκά - Ministry of Health

פלומה ים המלח בעמ - לחות והזנה לעור

Ισραήλ - Εβραϊκά - Ministry of Health

פלומה ים המלח בעמ - שיפור מראה העור

Ισραήλ - Εβραϊκά - Ministry of Health

sanofi israel ltd - clopidogrel as hydrogen sulfate - טבליות מצופות פילם - clopidogrel as hydrogen sulfate 75 mg - clopidogrel - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid

Ισραήλ - Εβραϊκά - Ministry of Health

sanofi - aventis israel ltd - clopidogrel as hydrogen sulfate 300 mg - film coated tablets - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid

Ισραήλ - Εβραϊκά - Ministry of Health

medici medical ltd, israel - streptococcus pneumoniae - תמיסה להזרקה - streptococcus pneumoniae 25 mcg / 0.5 ml - pneumococcus, purified polysaccharides antigen - pneumococcus, purified polysaccharides antigen - prevention of pneumococcal infections, particularly of the respiratory type, in patients presenting an increased risk over the age of 2 years.

Ισραήλ - Εβραϊκά - Ministry of Health

sanofi - aventis israel ltd - cromoglicic acid as sodium 2 %w/v - eye drops - cromoglicic acid - preventive treatment for all types of allergic conjunctivitis.